About this trial
The aim of this observational, retrospective study is to evaluate, comparatively, procedural outcomes of APs (Accessory pathway) ablation according to the conduction properties (i.e., manifest vs. concealed) and to assess both short- and long-term outcomes of RFA (RF ablation).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
EITHER clinical suspicion of paroxysmal supraventricular tachycardia without prior documentation of ventricular pre-excitation and/or supraventricular arrhythmia (SVA) on 12-lead surface electrocardiogram, OR with electrocardiographic evidence of SVA, AND electrophysiological confirmation of atrioventricular re-entrant tachycardia (AVRT) as the arrhythmic mechanism.
Aged between 5 to 60 years old
Disqualifiers
Lack of pre-specified follow-up: only patients with at least 1 years follow-up ambulatory visit will be included in the study
REDO CA procedure
Trial population
Patients who consecutively underwent an electrophysiological (EP) study at San Raffaele Scientific Institute for EP study due to paroxysmal SVT with documented acessory pathway
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Acute procedural success
Secondary outcomes
Procedural complexity
Durability of successful radiofrequency ablation
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: